Vidcast:  https://youtu.be/7nCgUcIjJNY

 

The Australian digital health startup ResApp will become part of the Pfizer family after $116 millionUS changes hands.  The ResApp mobile app analyses cough and other respirator sounds to help diagnose asthma, pneumonia, bronchitis, croups, and COPD.  The app might help with the diagnosis and staging of CoVid. 

 

https://www.startupdaily.net/topic/asx/pharma-giant-pfizer-wins-over-telehealth-startup-resapp-health-with-179-million-takeover/

 

#pfizer #resapp #respiratory #asthma #bronchitis #copd #CoVid